Science
Mechanism of Action
Upon topical application, Methyl Nicotinate functions as a rubefacient and vasodilator. Its primary mechanism involves stimulating the release of prostaglandin D2, which acts on capillary endothelial cells to induce localized cutaneous vasodilation. This process, also influenced by local sensory nerve activation, significantly increases microcirculation, resulting in temporary skin erythema and a distinct warming or tingling sensation.
Research
Clinical Evidence
High confidenceN/A
Key findings
- 01 Topical application of 20 mmol/L Methyl Nicotinate reliably induced a microvascular response in the skin, reaching a plateau between 5 and 20 minutes post-application.
- 02 Formulations containing 0.5% and 1.0% Methyl Nicotinate elicited a maximal skin response within 30 minutes, characterized by increased microcirculation, transepidermal water loss, and transient dermal edema.
- 03 Concentrations exceeding 10^-4 mol/L were shown to significantly enhance local blood flow.
Transparency
Dusting Analysis
The Formula
Formulation
Stability
Methyl Nicotinate demonstrates excellent chemical and biological stability in aqueous solutions when stored at 4°C. Its gradual degradation to nicotinic acid (approximately 0.5% per annum) does not significantly compromise its vasodilatory efficacy over prolonged storage periods, up to 1057 days. It maintains stability under standard handling and storage conditions.
Safety
Safety Profile
The Cosmetic Ingredient Review (CIR) has deferred evaluation, deferring to the FDA's assessment. The FDA has approved Methyl Nicotinate for use in Over-The-Counter (OTC) external analgesics (counter-irritants). It is known to induce local skin erythema and a warming/tingling sensation. It carries GHS hazard statements H315 (Causes skin irritation) and H319 (Causes serious eye irritation). However, EWG Skin Deep rates it as low risk for cancer, allergies & immunotoxicity, developmental and reproductive toxicity, and use restrictions.
Your Skin
Skin Compatibility
Our Assessment
Verdict
Methyl Nicotinate is a valuable active for targeted applications requiring enhanced microcirculation and skin conditioning, but its irritancy necessitates careful formulation and consideration for sensitive skin types.
Related
Similar Ingredients
Finding similar ingredients…